--- title: Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome description: SciSparc receives FDA approval for a Phase IIb trial of a cannabinoid-based treatment for Tourette Syndrome, addressing significant unmet medical needs. image: https://420intel.com/hubfs/AdobeStock_423786860.jpg --- [![420intel.com](https://420intel.com/hs-fs/hubfs/Asset%2016-1.png?width=300&height=162&name=Asset%2016-1.png "420intel.com")](https://420intel.com) - [Home](https://420intel.com) - [Advertise](https://420intel.com/advertise) - [Directory](https://420intel.com/directory) - [Topics](https://420intel.com/blog) - [Recreational News](https://420intel.com/blog/tag/recreational-cannabis-news) - [Business News](https://420intel.com/tag/cannabis-business-news) - [Politics](https://420intel.com/tag/cannabis-politics) - [Technology](https://420intel.com/tag/cannabis-technology-news) - [Research](https://420intel.com/tag/medical-cannabis-news) - [Contact](https://420intel.com/contact-us) - [Follow us on Facebook](https://www.facebook.com/420intel) - [Follow us on LinkedIn](https://www.linkedin.com/company/420-intel/) - [Follow us on Twitter](https://x.com/420intel) - [Follow us on Instagram](https://www.instagram.com/420intel) ### Press ESC to close [![420intel.com](https://420intel.com/hs-fs/hubfs/Asset%2016-1.png?width=300&height=162&name=Asset%2016-1.png "420intel.com")](https://420intel.com) - [Home](https://420intel.com) - [Advertise](https://420intel.com/advertise) - [Directory](https://420intel.com/directory) - [Topics](https://420intel.com/blog) - [Recreational News](https://420intel.com/blog/tag/recreational-cannabis-news) - [Business News](https://420intel.com/tag/cannabis-business-news) - [Politics](https://420intel.com/tag/cannabis-politics) - [Technology](https://420intel.com/tag/cannabis-technology-news) - [Research](https://420intel.com/tag/medical-cannabis-news) - [Contact](https://420intel.com/contact-us) - [Follow us on Facebook](https://www.facebook.com/420intel) - [Follow us on LinkedIn](https://www.linkedin.com/company/420-intel/) - [Follow us on Twitter](https://x.com/420intel) - [Follow us on Instagram](https://www.instagram.com/420intel) # Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome - [![Buzz](https://420intel.com/hs-fs/hubfs/Buzz-No%20Outline-2.png?width=80&height=80&name=Buzz-No%20Outline-2.png) Buzz](https://420intel.com/blog/author/buzz) - [Medical Cannabis News](https://420intel.com/blog/tag/medical-cannabis-news) - 1 October 2024 ## SciSparc receives FDA approval for a Phase IIb trial of a cannabinoid based treatment for Tourette Syndrome.   SciSparc Ltd., a clinical-stage pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has approved its investigational new drug (IND), which enables the company to proceed to Phase IIb clinical trial for its medication to treat Tourette Syndrome (TS).   This FDA approval is a significant milestone for the company as it seeks to address unmet medical needs in managing TS. ### **SciSparc Targets Unmet Medical** Tourette Syndrome is a complex neurological disorder that affects patients worldwide, especially children and adolescents. Existing treatments often fall short of effectively managing symptoms. "As the currently used medications are managing only a small number of disease symptoms with limited efficacy and questionable safety, we believe there is a clear unmet medical need for the management of TS," said SciSparc’s CEO, **Oz Adler**. ### **Global Clinical Trial To Start Soon** The upcoming Phase IIb trial will take place at three medical institutions: the Yale Child Study Center in Connecticut, the Hannover Medical School in Germany and the Tel Aviv Sourasky Medical Center in Israel.  This trial will focus on assessing the efficacy, safety, and tolerability in adult patients. “The therapy of choice should also have a favorable safety profile, allowing for high patient drug compliance,” Adler added. Participants in the trial will be randomized at a 1:1 ratio to receive either SCI-110 or a placebo. The trial will measure changes using the Yale Global Tic Severity Scale at weeks 12 and 26, with the primary safety objective being to assess serious adverse events across the patient population. ### **Cannabinoids And The Broader Vision** SciSparc is specialized in cannabinoid-based treatments for neurological disorders. Besides SCI-110 for TS, the company is also exploring its potential for Alzheimer's disease and agitation. “We believe our innovative drug candidate SCI-110 has the potential to be this desired therapy,” Adler said.   [by Rolando Garcia](https://www.benzinga.com/markets/cannabis/24/09/41107692/pharma-company-gets-fda-green-light-for-next-phase-trial-for-tourette-syndrome) [Medical Cannabis News](https://420intel.com/blog/tag/medical-cannabis-news) [Cannabis Technology News](https://420intel.com/blog/tag/cannabis-technology-news) ![Buzz](https://420intel.com/hs-fs/hubfs/Buzz-No%20Outline-2.png?width=200&height=200&name=Buzz-No%20Outline-2.png) #### [Buzz](https://420intel.com/blog/author/buzz) At 420 Intel, we cover cannabis legalization news throughout the world, offer reliable information for cannabis business owners, detail technological advances that impact the marijuana industry, cover marijuana rallies from across the globe, and everything in between. - - - [Cannabis Politics](https://420intel.com/blog/tag/cannabis-politics) [![DEA Forces Marijuana Pharma Drug Industry Offshore: A Symbol of DEA Systemic Obstruction Against Trump Administration Directives](https://420intel.com/hs-fs/hubfs/AI-Generated%20Media/Images/The%20image%20features%20a%20tense%20courtroom%20scene%20with%20lawyers%20and%20clients%20engaged%20in%20a%20heated%20discussion%20In%20the%20foreground%20Duane%20Boise%20the%20CEO%20of%20MMJ%20International%20Holdings%20is%20seen%20passionately%20gesturing%20while%20speaking%20to%20a%20group%20of%20supporters%20Behind%20him%20l.jpeg?width=550&height=395&name=The%20image%20features%20a%20tense%20courtroom%20scene%20with%20lawyers%20and%20clients%20engaged%20in%20a%20heated%20discussion%20In%20the%20foreground%20Duane%20Boise%20the%20CEO%20of%20MMJ%20International%20Holdings%20is%20seen%20passionately%20gesturing%20while%20speaking%20to%20a%20group%20of%20supporters%20Behind%20him%20l.jpeg)](https://420intel.com/blog/dea-forces-marijuana-pharma-drug-industry-offshore-a-symbol-of-dea-systemic-obstruction-against-trump-administration-directives) - [![Buzz](https://420intel.com/hs-fs/hubfs/Buzz-No%20Outline-2.png?width=80&height=80&name=Buzz-No%20Outline-2.png) Buzz](https://420intel.com/blog/author/buzz) - 31 March 2025 #### [DEA Forces Marijuana Pharma Drug Industry Offshore: A Symbol of DEA Systemic Obstruction Against Trump Administration Directives](https://420intel.com/blog/dea-forces-marijuana-pharma-drug-industry-offshore-a-symbol-of-dea-systemic-obstruction-against-trump-administration-directives) "The DEA's marijuana approach is stuck in an outdated ‘war on drugs' mentality," said Duane Boise... [Medical Cannabis News](https://420intel.com/blog/tag/medical-cannabis-news) [![DEA's 7-Year Hiccup on Marijuana for Patients](https://420intel.com/hs-fs/hubfs/AI-Generated%20Media/Images/The%20image%20depicts%20a%20tense%20scene%20inside%20a%20dimly%20lit%20conference%20room%20where%20three%20senior%20officials%20from%20the%20Drug%20Enforcement%20Administration%20DEA%20sit%20around%20a%20large%20oval%20table%20Thomas%20Prevoznik%20a%20middleaged%20man%20with%20saltandpepper%20hair%20appears%20visibly%20agita.jpeg?width=550&height=395&name=The%20image%20depicts%20a%20tense%20scene%20inside%20a%20dimly%20lit%20conference%20room%20where%20three%20senior%20officials%20from%20the%20Drug%20Enforcement%20Administration%20DEA%20sit%20around%20a%20large%20oval%20table%20Thomas%20Prevoznik%20a%20middleaged%20man%20with%20saltandpepper%20hair%20appears%20visibly%20agita.jpeg)](https://420intel.com/blog/deas-7-year-hiccup-on-marijuana-for-patients) - [![Buzz](https://420intel.com/hs-fs/hubfs/Buzz-No%20Outline-2.png?width=80&height=80&name=Buzz-No%20Outline-2.png) Buzz](https://420intel.com/blog/author/buzz) - 14 April 2025 #### [DEA's 7-Year Hiccup on Marijuana for Patients](https://420intel.com/blog/deas-7-year-hiccup-on-marijuana-for-patients) \[WASHINGTON, DC\] ACCESS Newswire / April 14, 2025 / Senior officials at the Drug Enforcement... [Cannabis Politics](https://420intel.com/blog/tag/cannabis-politics) [![Cannabis Rescheduling Feared ‘Dead’ Following Appointment of New DEA Administrator Maltz](https://420intel.com/hs-fs/hubfs/AI-Generated%20Media/Images/The%20image%20portrays%20a%20tense%20meeting%20room%20filled%20with%20concerned%20officials%20and%20advocates%2c%20all%20seated%20around%20a%20large%2c%20polished%20wooden%20table.jpeg?width=550&height=395&name=The%20image%20portrays%20a%20tense%20meeting%20room%20filled%20with%20concerned%20officials%20and%20advocates%2c%20all%20seated%20around%20a%20large%2c%20polished%20wooden%20table.jpeg)](https://420intel.com/blog/cannabis-rescheduling-feared-dead-following-appointment-of-new-dea-administrator-maltz) - [![Buzz](https://420intel.com/hs-fs/hubfs/Buzz-No%20Outline-2.png?width=80&height=80&name=Buzz-No%20Outline-2.png) Buzz](https://420intel.com/blog/author/buzz) - 23 January 2025 #### [Cannabis Rescheduling Feared ‘Dead’ Following Appointment of New DEA Administrator Maltz](https://420intel.com/blog/cannabis-rescheduling-feared-dead-following-appointment-of-new-dea-administrator-maltz) Cannabis rescheduling was dealt a major blow today as it was confirmed that long-time cannabis... - [Follow us on Facebook](https://www.facebook.com/420intel) - [Follow us on LinkedIn](https://www.linkedin.com/420intel) - [Follow us on Twitter](https://twitter.com/420intel) - [Follow us on Instagram](https://www.instagram.com/420intel) Back to Top ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Buzz", "url" : "https://420intel.com/blog/author/buzz" }, "dateModified" : "2024-10-15T17:33:23.299Z", "datePublished" : "2024-10-01T04:45:00.000Z", "headline" : "Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome", "image" : [ "https://420intel.com/hubfs/AdobeStock_423786860.jpg" ], "mainEntityOfPage" : { "@id" : "https://420intel.com/blog/pharma-company-gets-fda-green-light-for-next-phase-trial-for-tourette-syndrome", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://420intel.com/hubfs/Asset%2016.png" }, "name" : "420 Intel" } } ```